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AbstrACt
Introduction Childhood vaccination programmes have 
been established in all Organisation for Economic Co-
operation and Development (OECD) countries; however, 
measles, mumps and rubella (MMR) as well as diphtheria, 
tetanus, pertussis and polio (Tdap-IPV) vaccination rates 
are not optimal in adolescents. Education in combination 
with easy access vaccination may be a promising 
approach to improve vaccination rates. We aim at 
improving MMR and Tdap-IPV rates in a school setting in 
the context of a planned cluster randomised controlled trial 
(cRCT), the present paper describes the detailed protocol 
of this trial.
Methods and analysis We will conduct a school-
based cRCT, where schools will be randomised to either 
an educational condition addressing knowledge, risk 
communication and enhancing self-efficacy regarding 
vaccination or a low-intensity information condition. In 
both conditions, a bus equipped with medical staff and 
materials, will be delivering MMR and Tdap-IPV vaccine 
directly after the intervention. Schools in the city centre 
of Berlin, Germany, will be stratified by percentage of 
migration and type of school. Primary outcome is the 
number of students who receive vaccination in the bus. 
Secondary outcomes are knowledge and self-efficacy. 
An estimated sample size of 355 school classes with 
approximately 25 students per class is required. The 
planned analyses will take the nested structure of 
students, classes and schools into account.
Ethics and dissemination The study will be performed 
according to the principles of Good Clinical Practice 
and the Declaration of Helsinki. Approval was obtained 
by the local ethics committee. Parents of all students 
will be informed in advance. Their written consent 
will be obtained, in case students are underage. For 
dissemination, we will engage with governmental 
organisations to create potential of our educational unit to 
be included in future public health prevention schemes.
trial registration number ISRCTN18026662;Pre-results.
IntroduCtIon 
In many countries around the world the 
vaccination rates for measles, mumps and 
rubella (MMR) as well as for diphtheria, 
tetanus, pertussis and polio (Tdap-IPV) are 
decreasing again.1 2 In multiple European 
countries, such as the UK, France, Italy or 
Spain, several measles outbreaks with more 
than 1000 cases per year have been observed 
within the last 10 years.3 In 2015, 2465 measles 
cases were reported in Germany, of which 
more than 50% occurred in Berlin.3 One 
reason for this development is the low rate of 
the second MMR vaccine which is necessary 
for a lifetime vaccine protection. The most 
recent vaccination rates at school entrance 
health examinations in Berlin for the second 
vaccination were 92.2% for measles, and 
91.8% for mumps and rubella.1 For Berlin 
adolescents aged 16 years, these rates were 
even lower at their school entrance exam-
ination in 2008 with 88.2% for measles, and 
87.9% for mumps and rubella.4 To prevent 
the spreading of the virus, more than 95% 
population immunity through a two-dose 
vaccination regimen is warranted.5 Effective 
approaches to increase vaccination rates are 
needed and school-based interventions may 
be feasible.
strengths and limitations of this study
 ► Among the first randomised controlled trials target-
ing vaccinations with a large sample which delivers 
vaccinations on spot in combination with an educa-
tional unit.
 ► The intervention addressing knowledge, risk com-
munication and enhancing self-efficacy regarding 
vaccination will be suitable for regular use in schools 
across students with different socioeconomic and 
migration backgrounds.
 ► A limitation concerns the generalisability which is 
limited to students from schools in the city centre 
and urban areas.
 ► With regard to the vaccination rate, one limitation 
that needs to be addressed is the communication 
with parents. As an ethical standard, adolescents 
underage can only get vaccination if the vaccination 
cards and signed consent declarations by the par-
ents are brought from home.
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Although there is no evidence on school-based interven-
tions to increase vaccination rates for MMR or Tdap-IPV, 
there is a body of literature suggesting the effectiveness 
of such interventions for other types of vaccinations 
including sexually transmitted infections/human papillo-
mavirus (HPV)6–11 and influenza.12 13 Frequently, studies 
applied self-reported outcomes such as knowledge and 
self-efficacy,7–9 14 this draw on theories including Social 
Cognition Theory15 and Protection Motivation Theory.16 
However, a minority of studies provided the possibility of 
vaccination directly after the intervention was delivered or 
report objectively measured vaccination behaviour.6 12 13
There is mixed evidence about the association of vacci-
nation rates with migration status and socioeconomic 
background. While studies found lower vaccination rates 
for those being non-white and below the poverty level17 
others found associations in the opposite direction.18 
Research on the effectiveness of school-based MMR or 
Tdap-IPV vaccination interventions with educational 
classes in adolescents with varying migration and socio-
economic background is missing.
trial objectives
As vaccination rates are decreasing again, our mobile 
intervention targets an increase in vaccination rates by 
improving vaccination-related knowledge and self-ef-
ficacy in combination with the opportunity of on-spot 
vaccination. For the main trial of the Prevention Bus 
project, the primary hypothesis proposes that among 
adolescents in a school setting, the participation in 
on-spot vaccination is increased after an educational 
class compared with a low-intensity information class. 
In secondary hypotheses, knowledge regarding vacci-
nation and vaccination-related self-efficacy are assumed 
to be superior in the educational class condition than 
in the low-intensity class condition after intervention 
took place. It is assumed that an increase in knowl-
edge and self-efficacy has an influence on the vacci-
nation rate. A spillover effect may become possible if 
adolescents watch their peers having their vaccination 
cards checked and being vaccinated. This is discussed 
in more detail in the context of the theoretical frame-
work. Finally, post-hoc analyses of the intervention 
effectiveness by gender, migration and socioeconomic 
background, and type of school will provide further 
insights about the reach of the intervention for vulner-
able subgroups. Using the Prevention Bus as an inter-
vention strategy, barriers will be identified in terms of 
feasibility to increase the immunisation rates at Berlin 
schools.
theoretical framework
There are various theoretical models of health behaviour 
change that may be relevant for increasing vaccination 
rates. The present intervention refers to a framework of 
constructs from different theoretical models that have 
effectively been used as a theoretical ground in the devel-
opment of other vaccination intervention studies.8 14 19 It is 
assumed that vaccine-related self-efficacy and vaccine-re-
lated knowledge, as well as a cue to action are associated 
with an increase in vaccination coverage.20
Regarding behaviour change, the Social Cognitive 
Theory,15 21 which conceptually overlaps with Protection 
Motivation Theory in the context of vaccination,16 is 
applicable to change of appraisal such as outcome expec-
tancies about vaccination and vaccination-related self-ef-
ficacy. This outcome expectancy can be targeted through 
communication of facts, risks and benefits of vaccinations 
and infectious diseases. In the same way as knowledge 
transfer, social factors also are crucial for the develop-
ment of motivation for a health behaviour like getting a 
vaccination which can be enabled through observational 
learning with a fictive or a peer model who decides to 
have the vaccination card checked or to be vaccinated. 
Also with group discussions, for example, talking about 
fears and doubts,22 physical and emotional states can 
be improved and students can verbally persuade each 
other. Thus, addressing self-efficacy of the students by 
prompting their mastery experience, the direct possi-
bility to be vaccinated on-site makes the implementation 
of the behaviour more likely. The Health Belief Model23 
proposes that threat and perceived benefits (eg, tackled 
by knowledge provision) and self-efficacy, in conjunction 
with available cues to action increase the likelihood of 
engaging in health promoting behaviours such as vacci-
nation. Empirical studies have shown that on-spot vacci-
nation can help to increase the vaccination rate.12 13 The 
possibility of converting intention directly into behaviour 
after the educational unit, in addition to the promotion 
of vaccine-related knowledge and enhancing vaccine-re-
lated self-efficacy, can lead to a long-term consolidation 
of behaviour.
MEthods
The Prevention Bus project is designed to evaluate a 
school-based vaccination intervention that is mobile and 
provides low-threshold healthcare provision and health 
education for young people. The trial was registered 
previously on ISRCTN and is still ongoing.
study design
The planned study design of the main trial is outlined in 
figure 1. As preliminary work a pilot study will be carried 
out, starting 18 September 2017 and running for 4 weeks. 
The pilot phase was used for testing feasibility of access 
and recruitment strategies as well as testing measurement 
instruments and adequacy of our educational material. 
A publication of the results of the pilot study is planned. 
The main trial will be running subsequently through the 
whole winter and summer term until mid of July 2018. At 
each school we aim to be on-site for 5 days, performing 
at least three class units per day. With a successful 
recruitment, including the pilot study, we will spend 34 
weeks at various Berlin schools during this period. We 
will use the prevention bus for this trial, which enables 
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mobile medical care of the highest standard. The bus 
interior was converted by the Deutsche Bahn (German 
railway company) into a medical practice in 2016 and is 
equipped with cupboards, water tanks, electricity connec-
tions, waiting areas and refrigerators for the vaccines. A 
separate treatment room with a table, seats and a patient 
couch is available in the rear part of the bus for the vacci-
nation, which guarantees privacy and the possibility of 
resting after the vaccination. From the outside the bus is 
marked red-white and as medibus of the Deutsche Bahn. 
In addition, the Charité logo will be displayed digitally 
for our trial.
The planned two-arm cluster randomised controlled 
trial (cRCT) is going to comprise an educational class 
condition and a control condition that is a low-inten-
sity information class. Clusters will be randomised at 
school-level stratified by proportion of students with 
migration background and school type. In both condi-
tions, parents and students will be informed 1 week in 
advance about the Prevention Bus, including informa-
tion about the procedure at school, which will be carried 
out by nurses and physicians, and vaccines offered. The 
information about the project will be distributed to 
students and parents as an official letter with the support 
of the school director. The schools receive the materials 
sorted by class and date with preliminary notice by post in 
advance, on average 1 week ahead. Further, the parents 
will receive a consent form for vaccination in case students 
are underage. In order to meet needs of the different 
linguistic backgrounds of the students' families, the infor-
mation letter to the study is kept short, being a one pager. 
In addition to basic information about the study and the 
Figure 1 Flow chart of the study design.
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vaccinations offered, there is also a reference to the possi-
bility of making enquiries on site, by telephone or e-mail. 
Furthermore, attention is drawn to our homepage, where 
additional easily understandable material is available 
for both, parents and students. There they will also find 
information on vaccination in different languages such as 
Arabic, Turkish, Russian and Vietnamese, and a declara-
tion of consent that refers to the information provided.24 
In addition, students with parents who have no or only 
poor German language skills often play a mediating role 
in the real-life school-home context. Since we use the 
same way of communication, via the school management, 
we assume that students communicate as usual in such 
situations with their parents. The extent to which the 
migration background has an influence or not on the 
response to the declarations of consent will be examined 
in the secondary analyses of the data. When the bus is 
on-site at schools all students, including those underage, 
will be asked for their consent right before vaccination 
takes place. In Germany, parents' consent to the vacci-
nation of students under the age of 18 is considered as 
a necessary condition for the vaccination of underaged. 
However, the additional consent on-site to vaccinate given 
by the adolescents themselves is regarded as a sufficient 
condition to carry out an actual vaccination. If underage 
students decide to be vaccinated but their parents have 
not yet given their consent, they have the opportunity to 
get a new consent form from the bus team on-site and 
present it to their parents at home and to receive vacci-
nations on one of the following days, while the bus is still 
at their school.
At school-level, schools with upper secondary educa-
tion/vocational schools will be eligible to be included 
in the trial if they are located in a borough of the city 
centre of Berlin, Germany. All boroughs, which are at 
least partly within the Berlin circle line, are defined as 
city centre. Circle line serves as a definition criterion 
for the centre of Berlin, as it provides a clear distinction 
between central and suburb area of Berlin. In addition, 
the time should be used to the maximum and the bus, 
which depot is located in a central borough, should have 
time-efficient routes. Schools with less than 200 students 
in the classes from 9th to 11th grade in upper secondary 
schools or for all apprentices in their teaching facilities 
are not eligible. Originally, all schools with fewer than 230 
students were to be excluded, but as classes were smaller 
than expected, this led to an adjustment of the minimum 
number. At class level, all classes participating in regular 
classes, meeting the criteria listed above, are included in 
the study. However, in some schools in Berlin in this age 
group, there are so-called ‘welcome classes’ (Willkom-
mensklassen). These adolescents have limited knowledge 
of German, because they have not yet lived in Germany for 
long since they recently emigrated from their homeland. 
In these classes, a vaccination card control is offered if 
required and teaching in simplified German is carried out 
if time resources are available. Nonetheless, these classes 
will not be part of the sample. On an individual-level, 
students will be included when aged minimum 15 years 
and for on-spot vaccination additionally a signed consent 
form is required, when students are underage, it needs to 
be signed additionally by the parents.
When schools are contacted, the recruiting person will 
be blinded to the intervention allocation of the school, as 
the intervention condition is blacked out on the school 
list. The recruiting person therefore has no knowledge of 
the assignment during recruitment. For each cluster (eg, 
high school with high migration status), the same number 
of schools are first contacted by postal mail and asked to 
participate. In addition to the personal cover letter, there 
will be an information flyer. Within this first contact, 
the general project is described and that 45–90 min are 
required per class. If no feedback is received, the school 
will be reminded of the project by email once more with 
information material. In further absence of feedback, a 
telephone call and/or a personal appointment are then 
scheduled. If a school cancels despite all activities, another 
school within the same cluster will be contacted. The 
cluster lists all available schools, all of which were previ-
ously assigned randomly to the intervention conditions.
Intervention and control condition
When the Prevention Bus is at a school, all students will 
be given the possibility to get information and vaccina-
tion if needed. Besides that, there will be the intervention 
taking part in the classes from 9th to 11th grade in high 
schools and for all apprentices in their teaching facilities. 
Either the class will be an educational class condition or a 
low-intensity information condition based on the rando-
misation. Trained physicians and nurses will deliver the 
intervention at schools. For organisational reasons, they 
will know to which intervention condition the school 
belongs, from the moment they arrive at the school. 
However, in advance neither the school staff nor the 
students will be aware of the details about the other condi-
tion of intervention. There will be a debriefing at the end 
of the school year. All headmasters will be informed by 
mail about the level of intensity of the information given 
in the class. Via the headmasters, the information is to be 
passed on to the respective class teachers and students, 
who have participated in the trial.
The educational class condition is scheduled with 90 min 
and the low-intensity information condition with 45 min. 
Both units for each class will begin in the classroom but 
differ in the amount and format of information provided. 
Both groups in the beginning will receive basic informa-
tion on the Prevention Bus and vaccinations offered and 
that they can be vaccinated directly afterwards in the bus, 
if a vaccination is outstanding, they decide positively for 
a vaccination and they have the signed parent consent 
thereby. The educational class condition will focus on 
knowledge, risk communication and enhancing self-ef-
ficacy regarding vaccination. The low-intensity informa-
tion condition will only give basic information. Detailed 
differences are described below. Both conditions include 
an anonymous questionnaire on sociodemographic 
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background, self-efficacy and knowledge regarding 
vaccination, which is delivered in the classroom, before 
students go to the bus. Furthermore, the check of the 
vaccination card in the classroom and a guided tour 
through the Prevention Bus, led by two nurses, will be 
part of the intervention for both groups. In both cases, 
the language of instruction will be German. One focus 
of the study is on the migration background of adoles-
cents which in some schools can be very high. However, 
the intervention takes place under real conditions and 
students in all participating classes also take part in 
regular German-language lessons in everyday school life. 
Nevertheless, the training of the physicians was designed 
in advance to adapt to different contexts. Following the 
class, the physicians will fill out a short quality assurance 
questionnaire which will allow double checks to study 
data (teaching quality, problems, number of students, 
number of vaccination cards). After the bus tour, all 
students with an indication and with a signed consent 
form, by themselves and additionally by their parents 
if student is underage, can be vaccinated. Even though 
underage students need parental consent for vaccination, 
the final decision to be vaccinated is up to the students 
themselves. For ethical demands, no link may be estab-
lished between the questionnaire data from the class and 
the individual data after vaccination. On an anonymous 
level, the class and the sociodemographic background 
are again collected from the vaccinee. Demands will be 
elaborated further in the Ethics approval and consent 
to participate section. All students who receive vaccina-
tions are vaccinated in the separate treatment room at 
the rear of the bus. Students do not watch each other 
getting vaccinated. However, their peers will accompany 
them when they walk from the classroom to the bus which 
may increase social commitment, but guarantees privacy 
at the same time. If desired, adolescents may be accom-
panied by their peers during vaccination. Since the bus 
is always on-site for several days, students without signed 
parental consent and/or vaccination card are always 
offered to have their vaccination card checked on the bus 
in the following days and to be vaccinated if necessary. 
This is done regardless of the condition of the interven-
tion. If the students are underage, the bus team will also 
give them a consent form to take home for the parents. In 
this way, students can discuss with their parents the vacci-
nation decision in more detail. In order to assess lagged 
decisions, additional documentation will be provided. If 
students are subsequently on the bus for the check of the 
vaccination card and/or vaccination, the date (distance 
to intervention), their class and the questionnaire on 
sociodemographic background are documented. This 
corresponds to the same procedure for students who are 
vaccinated immediately after the educational unit.
Content of conditions
The educational class consists of a digital Power-
point presentation held by a physician, including photo 
and video material which allows standardised information 
delivery. In addition to the standardised digital presenta-
tion, all intervention facilitators will obtain a script for the 
presentation, and they will be training the presentation 
in front of the study team in advance including frequent 
feedback of experienced colleagues before and during 
the trial. The amount of information provided is intended 
to be kept at a low level but still capturing all relevant 
aspects. In addition, presentation of content will be fit to 
the target group as described further on (eg, wording, 
use of photo and video material, activating elements). 
Informed by Social Cognition and Protection Motivation 
Theory,15 16 the content of the class will be targeting three 
mechanisms, that is, increasing knowledge by provision 
and questioning of information,25 risk perception by risk 
communication,26 enhancing self-efficacy27 by a testimo-
nial and a guided group discussion. Information on the 
basics of the immune system and the vaccination process 
will be provided in order to understand how vaccines 
work. Throughout the class, knowledge of the students 
will be questioned and corrected if necessary. In addition, 
background information will be given on all seven infec-
tious diseases against which vaccinations are offered on 
spot at the bus. Further, information on social aspects will 
be given, addressing herd and nest immunity (ie, vacci-
nations protect not only oneself but also other people.). 
The exchange of different perspectives and experi-
ences considers also emotional dimensions, important 
for lasting learning. All physicians, who will conduct 
the educational unit, are trained to adopt a cooperative 
teaching format.28–30 Provision of information and ques-
tioning of knowledge was chosen as an interactive and 
constructive method of connecting new information 
with prior knowledge. This also includes frequent feed-
back rounds conducted by research associates involved in 
the development of the educational class. Adequacy and 
feasibility of the educational class unit will be tested in the 
piloting phase. Changes will be made for the main trial if 
necessary.
Risks and advantages of vaccinations are communicated 
in detail on measles. Adapted to the target group, chances 
will be communicated in whole numbers supported 
by graphical depictions (eg, 93 out of 100 students get 
infected with measles if they are not vaccinated). In order 
to enhance self-efficacy regarding vaccination, a group 
discussion is initiated by the physician after the basics of 
the vaccination process are implemented. Triggered by 
a fictive social media post of a fictive person (ie, testimo-
nial/role model), with a gender-neutral name and look, 
students have the opportunity to exchange with each 
other about negative apprehensions, doubts and ques-
tions they have on vaccinations. In the end of the class, 
the ideas such as social aspects and risk-associated knowl-
edge will be taken up again and will be reflected. The 
questionnaire will be filled out after the class has finished. 
The intervention will end with a guided tour through the 
Prevention Bus, where vaccination will take place.
The low-intensity information group will get a brief 
introduction to the project and the Prevention Bus (‘Why 
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are we here’) lasting about 5 min. No more information is 
provided. Identically to the educational class group, the 
questionnaire will be filled out in the classroom. Subse-
quently, the class gets a guided tour through the bus, 
where also vaccinations are offered.
Parents in both groups will be informed in an identical 
manner about the project and vaccinations offered at 
least 1 week prior to the intervention. Apart from general 
information about the project, the announcement 
will include a declaration of informed consent to allow 
vaccination of their children, when underage, as well as 
detailed health information regarding the diseases and 
vaccinations. All parents do have the opportunity to get 
more information on the project website and via phone 
or email which will be attended by a study assistant.
outcome assessment
The primary outcome will be composite MMR and 
Tdap-IPV vaccination rate. Vaccination rate is objectively 
measured through the number of students who get vacci-
nated, directly after receiving treatment (educational 
class condition, low-intensity information condition) 
when students visit the Prevention Bus and those students 
who get vaccinated subsequently in the following days, 
when the bus is still on-site. The primary outcome will be 
weighted by the number of students who are eligible to 
take part in the study.
Secondary outcome are health knowledge and self-ef-
ficacy. Following outcome-based teaching theory (ie, 
constructive alignment of the content of teaching with 
test items31), health knowledge will be measured with 
six immunisation knowledge items, reflecting the main 
topics of the intervention.
Self-efficacy concerning the competency to understand 
and appraise vaccination related health information is 
measured using a five items short-version of the Euro-
pean Health Literacy Survey Questionnaire 47, where we 
selected those items, which were addressing prevention 
and immunisation treatment.32 33
The questionnaire will be administered before students 
visit the bus while they are still in their classroom. The 
data entry will be carried out by the bus team (nurses, 
physicians) directly after the intervention has taken place.
Additionally, potential confounders including gender, 
socioeconomic and migration status, and vaccination 
status will be assessed (ie, objective vaccination status 
prior to the intervention taken from students’ vaccination 
cards). In addition to mumps, measles, rubella, tetanus, 
diphtheria, pertussis and polio, the vaccination status of 
all other vaccinations recommended by the Permanent 
Vaccination Committee of the German government’s 
central scientific institution the Robert Koch-Institute will 
be documented.
randomisation
In a first step, all eligible schools in Berlin are contacted 
via the head of school following a stratified random order 
until 30 schools will be confirming participation. Strata 
will be (a) percentage of adolescents with migration back-
ground (below vs above median) and (b) type of school 
(high school, vocational school, integrated secondary 
school) using RAND function in Microsoft Excel 2013. 
Further, a stratified school-level cluster block randomisa-
tion to either educational class or low-intensity informa-
tion condition with strata using blockrand package in R 
V.3.2.1 was performed.
Estimated sample size
Within this trial, in all, 30 schools (high school, vocational 
school, integrated secondary school) will be approached. 
At each school, the team of the prevention bus aims to 
be on-site for 5 days and will address at least three school 
classes per day. This results in an anticipated sample size 
of 510 school classes for the entire survey period. In the 
city centre of Berlin, there are a total of 19 vocational 
schools, 15 integrated secondary schools and 41 high 
schools which are potential candidates for our model 
project.
In correspondence with our intervention procedure 
and to avoid contamination, the unit of randomisation 
was school. This will result in establishing a cRCT design 
where units (ie, classes) were randomised together in 
clusters (ie, schools). We expect potential contamination 
effects to be moderate within classes (ie, across students 
within one class), but smaller across classes within one 
school.8 9 Further, the education was delivered at class 
level. Thus, we decided the unit of sample size estimation 
will be class.
In the planned cRCT, stratified by school type and 
migration rate, the schools are randomly assigned with 
a 1:1 ratio to either the educational condition or low-in-
tensity information condition. In order to achieve an 
adequate vaccination coverage of 97% in the primary 
endpoint (MMR, Tdap-IPV vaccination) on a class-level, a 
required sample size of 355 school classes was determined 
a-priori (z-test; 88% MMR initial vaccine rate and a differ-
ence to the control group of 7%). The estimation is based 
on an intraclass coefficient of 0.02,13 a one-sided alpha-
level of 0.05 and a statistical power of 0.8 using GPower 
V.3.1.9.2.34
risk assessment
Risks and disadvantages are not to be expected from 
the intervention. For MMR and Tdap-IPV vaccinations, 
vaccination side effects are expected to be minimal, and 
serious side effects are expected to be extremely rare.35 36 
The likelihood of occurrence of vaccination complica-
tions (eg, transient therapies-related disease) is in the 
range of 1 per 1000.37 However, detailed information and 
medical history takes place before vaccination. According 
to the recommendations of the Permanent Vaccination 
Committee of the German government’s central scientific 
institution the Robert Koch-Institute, before the adminis-
tration of vaccination, detailed information on vaccina-
tion and vaccination complications must be provided.24 
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As part of our study quality assurance, negative events will 
be recorded and reported.
Ethics approval and consent to participate
An information letter about the project for parents and 
children and a letter with detailed information on MMR 
and Tdap-IPV vaccination asking for consent to partici-
pate will be sent to the school 1 week before the project 
was implemented in respective schools. Schools distrib-
uted the information material to every class through class 
teachers. Thereby, the study team would not be contacting 
the parents directly. To protect the personal informa-
tion and rights of the students, the ethics committee has 
mandated that questionnaire data from the classroom 
should not be linked to vaccination data from the preven-
tion bus which will allow us to carry out certain analyses 
only at the class level.
Analysis plan
Primary and secondary outcomes by intervention allo-
cation will be analysed applying Generalized Estimation 
Equations adjusting for the nested structure (ie, school, 
classes, students) to regress individual-level on-site vacci-
nation rate/knowledge/ self-efficacy on intervention 
condition when accounting for individual-level type 
of vaccination received, class-level socioeconomic and 
migration status, age and school-level type of school using 
GENLIN procedure in SPSS V.25. Results will be reported 
by the unit of randomisation (ie, by schools) and as overall 
estimated averages for intervention and control condi-
tion. Missing data >5% will be handled using multiple 
imputation. Post-hoc analyses, which do not match class 
room questionnaire data with on-site vaccination data, 
but refer to just one of these, will be possible on an indi-
vidual level of analysis and will be analysed using mixed 
modelling accounting for clustering of students within 
classes within schools.
Patient and public involvement
Intensive dialogues with political members of the German 
Federal Ministry of Health drove the development of the 
research question, and we have been discussing the rele-
vance and the design of the study with the headmasters 
of schools. Subsequently, students are involved in the 
design of this study as part of the piloting as described. 
Further, within the pilot phase, we will be testing all 
outcome measures which will be adjusted according to 
the feedback of the students. The students’ priorities 
and preferences were taken into account by extent and 
format of information presented. However, students will 
not be involved in the recruitment and conduct of the 
study. After the main trial, all students will be informed 
via the headmasters and the respective teachers by infor-
mation provision on details of the educational unit as well 
as on the background of the study and results regarding 
vaccination rate, and related knowledge and self-efficacy 
regarding vaccination. Further, we will allow all students 
to contact us via mail for additional questions or doubts. 
Finally, although we do not include a formal assessment 
of participant burden, students within the pilot and the 
main phase will be invited to provide feedback about posi-
tive and challenging issues with a short online question-
naire provided to the headmasters of their schools. For 
further dissemination of the educational unit, beyond 
this trial, we will be in contact with governmental institu-
tions including the German Federal Ministry of Health. 
We aim to ensure that the educational unit will inform 
the national prevention strategy.38
dIsCussIon
The objective of this article was to describe our planned 
school-based educational and on-site MMR and Tdap-IPV 
vaccination intervention. The findings of our cRCT 
will provide evidence on the accessibility of adolescents 
to mobile on-site healthcare services as well as on their 
vaccination uptake. In the context of the Social Cogni-
tive Theory, our educational intervention targeting 
three mechanisms, that is, increasing knowledge25 and 
risk perception,26 and enhancing self-efficacy.27 These 
mechanisms are expected to work in combination with 
an on-site MMR and Tdap-IPV vaccination opportunity 
directly after the educational class took place.
By means of our trial, results might lead to an increase 
in the vaccination rate which is of great public health rele-
vance. By June 2018, again more than 200 measles cases 
had already been reported in Germany.3 The national 
vaccination target of removing measles in Germany by 
202038 is a long way off and intervention projects like 
ours are urgently needed. Further, for the goal of broad 
acceptance of vaccinations of the WHO,39 our proposed 
intervention appears to be an appropriate tool to reach 
adolescents at scale.
strengths and limitations
Our study will be among the first randomised controlled 
trials targeting vaccinations with a large sample which 
delivers vaccinations on spot in combination with an 
educational unit suitable for regular use in schools. The 
mobile approach enables an extremely efficient, compre-
hensive supply of vaccinations. Moreover, we address 
adolescents who, because of their age, soon become 
multipliers in their professional or family environment.
Our study has several limitations worth noting. With 
regard to the vaccination rate, one limitation that needs 
to be addressed is the communication with parents. As 
an ethical standard, the vaccination rate can only be 
collected and, if necessary, adolescents vaccinated if the 
vaccination cards and consent declarations are brought 
from home. A greater focus on methods of communica-
tion is likely to be relevant for future studies. Due to time 
constrictions, we will administer the questionnaire in the 
educational class unit only after the class is held. Although 
baseline assessments allow for controlling for baseline 
differences across groups, in RCT designs, differences 
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are controlled by the randomisation procedure and are 
purely by chance.40
Future research
In addition to MMR and Tdap-IPV vaccinations, future 
studies should address HPV vaccinations, as this is still 
a relatively recent vaccination. The mobile approach of 
carrying out vaccination programmes supported by a 
medical team and a bus with vaccinations offered on spot 
seem to be a fruitful public health strategy. This especially 
holds true for urban spaces like Berlin, where vaccina-
tion rates are far from being optimal.4 Policy has to deal 
with how such offers can be meaningfully integrated into 
their political agenda and subsequently into healthcare 
practice. While local physicians are supported by such an 
approach; likewise, it would be possible to include them 
in the design of mobile vaccination strategies. Further, 
possibilities of mobile medical strategies for medically 
underserved regions lacking preventive health such as 
certain rural areas should be developed and evaluated 
in order to improve their healthcare quality. Along these 
lines, synergy can be created between public health strat-
egies and day-to-day medical care.
Conclusion
The innovative approach of providing education and 
vaccinations with a bus by mobile means enables attrac-
tive routes for medicine and politics to provide compre-
hensive preventive medical care. Given this background, 
the use and dissemination of evidence-based educa-
tional materials to the public is extremely valuable. In 
the future, we will be confronted with ever more struc-
tural changes in the population in urban and rural areas, 
where mobile healthcare services carry an opportunity to 
optimise healthcare delivery cooperatively and evidence 
based interventions are urgently needed.
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